548BIOCHEMICAL SOCIETY TRANSACTIONS dione); 1 1flOH-P (1 1/?-hydroxyprogesterone; 1 1 /?-hydroxypregn-4ene-3,20-dione); 1 I-0x0-P (1 1-oxoprogesterone; pregn-4-ene-3,11,20trione); 21-d-F (2 I-deoxycortisol; 11/?,17a-dihydroxypregn-4-ene-3,20dione); 2 1 -d-E (2 1-deoxycortisone; 17a-hydroxypregn-4-ene-3,11,20trione); 1 1-deoxycortisol (Reichstein's substance S ; cortexolone; 1 7~2 l-dihydroxypregn-4-ene-3,20-dione); DHS (dihydro substance S; dihydro-1 1-deoxycortisol; 1 7a,2 1 -dihydroxy-5/?,pregnane-3,20-dione); THS (5fltetrahydro substance S ; tetrahydro-I 1-deoxycortisol; 3/?,17a,21-trihydroxy-5/?-pregnan-20-one); DOC (1 l-deoxycorticosterone; cortexone; 2 1 -hydroxypregn-4-ene-3,2O-dione); TH-DOC (tetrahydro-1 1-deoxycorticosterone; 342 l-dihydroxy-5/?-pregnan-20one); aldosterone (1 lp,2 l-dihydroxy-pregn-4-ene-3,18,2O-trione); 2a-Me,9a-FI-F (9a-fluoro-2a-methyl-1 I/?, 17a,21-trihydroxypregn-4ene-3,20-dione); glycyrrhetinic acid (glycyrrhetic acid; 3Fhydroxy-1 I-oxo-olean-12-en-30-oic acid); brassinolide [2 a,3 a,(ZZR)-(23R)-tetra hydroxy-(24S)-methyl-B-homo-7-oxa-5a-cholestan-6-onel.